Company · CIK 1600620

# Aurinia Pharmaceuticals Inc.

| CIK | [1600620](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001600620) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | Alberta, Canada |
| Listed | AUPH (Nasdaq) |
| First annual or quarterly report | 2015-03-30 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-261242 | Shelf Effective | 2021-11-19 | 2021-11-19 | 1 |

## Filings

 4

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2021-11-19 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1600620/000119312521335311/0001193125-21-335311-index.htm) Shelf registered | 333-261242 | 0001193125-21-335311 |
| 2020-06-19 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1600620/999999999520001488/9999999995-20-001488-index.htm) Declared effective | 333-238785 | 9999999995-20-001488 |
| 2018-03-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1600620/999999999518000708/9999999995-18-000708-index.htm) Declared effective | 333-222413 | 9999999995-18-000708 |
| 2015-11-05 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1600620/999999999515002978/9999999995-15-002978-index.htm) Declared effective | 333-206994 | 9999999995-15-002978 |

[All filings of this company](https://equitycapital.markets/filings?cik=1600620) · [CSV](https://equitycapital.markets/filings.csv?cik=1600620)

---
Source page: https://equitycapital.markets/company/1600620 · Data: U.S. SEC EDGAR · CC BY 4.0